Skip to content

Powerful Perceptions of Genetic Information.

Sep 2026 · Journal of Clinical Ethics · Vol 37 3, pp. 241-248 · 0 citations · 27 references
Medicine

Abstract

AbstractResearchers who focus on the ethical, legal, and social implications (ELSI) of genetics have tried to anticipate and mitigate the unique risks of genetic testing. To that end, ELSI scholars have focused on the unique predictive power and the subtle ambiguities of genetic test results. Much of this work has assumed that genomic results accurately predict future health problems and has considered the implications of these accurate predictions for the benefits and harms that may result from access to such test results. In this article, we consider a different type of risk-a type of exceptionalism we term "genetic bias." Genetic bias occurs when genomic results have uncertain implications but are perceived as more accurate and accurately predictive than is warranted. Such bias can lead to inappropriate clinical decisions. Specifically, if the genomic results are thought to be more definitive than they really are, they may lead to undue limitations in care. We explore genetic bias through the lens of neonatology, where burgeoning use of genetic testing routinely impacts everyday medical decision-making. Our concerns are supported by preliminary evidence that both neonatologists and parents harbor genetic biases. We examine the implications of this bias and suggest ways that the detrimental effect of such biases could be mitigated.

View source

Similar papers

Open access Sep 2026

Living in a genetic penumbra: navigating uncertainty and morality

Examining how users of Reddit communities dedicated to bipolar disorder make sense of an unknown amount of genetic risk through analysis of online discussions on Reddit offers a new concept called genetic penumbra to explicate how individuals make sense of genetic risk while living under the shadow of genetic uncertain...

Jonathan Henry, P. Sankar, P. Sahota · 0 citations
Open access Sep 2026

Polygenic Prediction: How Contested Genetic Technologies Organize Fields of Expertise

Abstract Prediction has long been a feature of medical genetics. Yet with the advent of polygenic indices (PGIs), there has been a fundamental shift in the complexity and ambiguity of the predictive power afforded by genetics. These indices, which use large datasets to estimate how genetic variants relate to phenotype,...

Z. Griffen, Aaron Panofsky · 0 citations
Open access Aug 2026

Public perceptions of polygenic testing and embryo selection for non-medical traits.

Public views on polygenic embryo testing are examined, suggesting variability in choices across specific traits and conditions, rather than a uniform distinction between medical conditions and non-medical traits.

Edmond Awad, Clara Colombatto, J. Demaree-Cotton et al. · 0 citations
Open access Oct 2026

A Conceptual Roadmap toward Informed Prenatal Genetic Screening and Diagnostic Testing: A Qualitative Study.

INTRODUCTION Prenatal genetic screening and diagnostic tests (PS&D) are a core component of the delivery of high-quality, evidence-based prenatal care. There is a paucity of evidence on how to structure decision-making processes that are responsive to rapid advances in prenatal genetics, perinatology, and neonatology,...

Miller S. Finkelstein, John F. P. Bridges, Norah L. Crossnohere et al. · 0 citations
Review Sep 2026

Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population.

Cancer susceptibility testing is rapidly advancing beyond specialist genetics clinics into routine oncology and population-level genomics initiatives. This expansion positions germline pathogenic variants in cancer susceptibility genes and polygenic risk scores as crucial tools for precision prevention, surveillance, a...

Clare Turnbull, Sandra Perdomo, S. Domchek et al. · 1 citation
Oct 2026

Ethics of opportunistic genomic screening in paediatrics: rethinking the risk-benefit ratio.

Genome-wide sequencing (GWS) has become an important tool in paediatric medicine, but it may uncover secondary findings (SFs) through opportunistic screening. The disclosure of adult-onset SFs in children, who cannot consent, raises ethical concerns regarding potential psychosocial harm and future autonomy. This paper...

Emily Wheeler, Wayne Shelton, G. Geis · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.